Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Its shares fell nearly 50 percent in 2025 and are down a further 15 percent this year, while the company now expects sales and profit to decline 5 percent13 percent in 2026, mainly because of US pricing pressure and loss of semaglutide exclusivity in markets such as Canada and China, according to CNBC
In June, Canadian health officials approved a generic version of Novo Nordisks Wegovy medication to be used as a treatment for weight loss
P., & Sugiarto, D
I will definitely go back and I will recommend to my friends and family
US$ 26.32
US$ 29.12
US$ 26.27
US$ 29.16
